← Back

Predilife

Predilife S.A. designs and markets predictive tests for serious illnesses. Its offerings include breast cancer and multi-pathology predictive assessments, the Care4Eat nutrition assessment for employees, the MammoRisk breast cancer prediction test based on individual risk, and DenSeeMammo, a breast density measurement software. The company was incorporated in 2004 and is headquartered in Villejuif, France.

Price · split & dividend adjusted
News & notes moving ALPRE.PA